Busulfan Injection Clinical Trials

• Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors
  ClinicalTrials.gov Identifier: NCT00003462 - Active, not recruiting
  leptomeningeal metastases
  
• Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00092937 - Active, not recruiting
  Granulomatous Disease; Chronic
  
• Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantaion: a Pharmockinetic Study
  ClinicalTrials.gov Identifier: NCT00156858 - Recruiting
  Hematologic Malignancy
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• Busulfan and Fludarabine in Patients With AML and MDS
  ClinicalTrials.gov Identifier: NCT00502905 - Active, not recruiting
  Leukemia
  
• Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support
  ClinicalTrials.gov Identifier: NCT00506857 - Active, not recruiting
  Hematologic Malignancies
  
• Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00005866 - Active, not recruiting
  untreated adult acute myeloid leukemia; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome; ...
  
• Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00534430 - Active, not recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Busulfan, Etoposide, and Total-Body Irradiation Followed by Autologous Stem Cell Transplant and Aldesleukin in Treating Patients With Acute Myeloid Leukemia in First Remission
  ClinicalTrials.gov Identifier: NCT00534469 - Active, not recruiting
  Leukemia
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors
  ClinicalTrials.gov Identifier: NCT00436761 - Active, not recruiting
  Unspecified Childhood Solid Tumor, Protocol Specific
  
• Imatinib Mesylate, Busulfan, Fludarabine, and ATG for CML Patients
  ClinicalTrials.gov Identifier: NCT00499889 - Recruiting
  Leukemia
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• Chemotherapy and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002547 - Active, not recruiting
  Leukemia
  
• Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00301951 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003661 - Active, not recruiting
  Leukemia; Lymphoma
  
• Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00363467 - Recruiting
  Acute Myeloid Leukemia (AML)
  
• Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies
  ClinicalTrials.gov Identifier: NCT00410982 - Recruiting
  Leukemia; Lymphoma; Myeloma
  
• Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors
  ClinicalTrials.gov Identifier: NCT00357396 - Recruiting
  Sarcoma
  
• Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00005641 - Active, not recruiting
  Leukemia; Multiple Myeloma
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
  ClinicalTrials.gov Identifier: NCT00361140 - Recruiting
  Myelodysplastic Syndromes; Myeloproliferative Disorders; Leukemia, Lymphocytic; Myeloma; Lymphoma
  
• Busulfan, Etoposide, Intensity-Modulated Radiation Therapy, and Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer
  ClinicalTrials.gov Identifier: NCT00540995 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003270 - Active, not recruiting
  Lymphoma; Leukemia; Multiple Myeloma
  
• Respiratory Side Effects of Busulfan High Dose Chemotherapy in a Pediatric Population
  ClinicalTrials.gov Identifier: NCT00328029 - Recruiting
  Signs and Symptoms, Respiratory
  
• Busulfan, Cyclophosphamide, Melphalan, and Donor Stem Cell Transplant in Treating Young Patients For Juvenile Myelomonocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00262756 - Recruiting
  Leukemia
  
• Cyclophosphamide and Busulfan Followed By Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00445744 - Recruiting
  Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
  
• A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT
  ClinicalTrials.gov Identifier: NCT00477542 - Recruiting
  Hematologic Malignancies
  
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
  Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
  
• Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002989 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma
  
• UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00113919 - Active, not recruiting
  Multiple Myeloma
  
• Adverse Drug Reactions of Different Brands of Ceftazidime Injection
  ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
  Infection
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00002831 - Active, not recruiting
  Leukemia, Myeloid; Leukemia, Myeloid, Chronic
  
• Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
  ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
  Pain
  
• Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00238433 - Recruiting
  Lymphoma
  
• Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00555048 - Recruiting
  Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00427765 - Recruiting
  Multiple Myeloma; Lymphoma
  
• Validation of Self-Reported Needle Sharing Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
  Viral Infection
  
• Phase I/II Study of Stem Cell Transplantation for Aggressive Acute Leukemias Using Clofarabine and Busulfan Regimen
  ClinicalTrials.gov Identifier: NCT00556452 - Recruiting
  Acute Leukemias; Chronic Myelogenous Leukemia
  
• Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
  ClinicalTrials.gov Identifier: NCT00070135 - Recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Phase II Trial of Pentostatin and Targeted Busulfan
  ClinicalTrials.gov Identifier: NCT00496340 - Not yet recruiting
  Hematologic Malignancies
  
• EPC by Intracoronary Injection in Patients With Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
  Coronary Artery Disease
  
• A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
  Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
  
• Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
  ClinicalTrials.gov Identifier: NCT00301834 - Recruiting
  Congenital Amegakaryocytic Thrombocytopenia; Diamond-Blackfan Anemia; Leukemia; Myelodysplastic Syndromes; Severe Congenital Neutropenia
  
• Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
  ClinicalTrials.gov Identifier: NCT00448201 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Fludarabine, Busulfan, and Alemtuzumab Followed By Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
  ClinicalTrials.gov Identifier: NCT00448357 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
  chronic phase chronic myelogenous leukemia
  
• The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
  ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
  Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
  
• Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
  ClinicalTrials.gov Identifier: NCT00006246 - Completed
  Leukemia; Brain Tumor; Lymphoma
  
• Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
  Type A Botulinum Toxin; Tennis Elbow
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003972 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
  ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
  Myocardial Infarction; Heart Failure, Congestive
  
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
  Psoriasis
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
  ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
  Schizophrenia
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
  ClinicalTrials.gov Identifier: NCT00491712 - Active, not recruiting
  Neovascular Glaucoma
  
• Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002961 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; childhood acute lymphoblastic leukemia in remission
  
• A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218192 - Active, not recruiting
  HCV Negative Status; HCV Risk Behavior
  
• A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
  ClinicalTrials.gov Identifier: NCT00225095 - Active, not recruiting
  Recovery Following Partial Medial Meniscectomy
  
• Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00301912 - Recruiting
  Anemia; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
  Colorectal Neoplasms
  
• Chemotherapy with Hematopoietic Stem Cell Support for Children with High Risk Solid Tumors and Lymphomas
  ClinicalTrials.gov Identifier: NCT00152126 - Active, not recruiting
  Neuroblastoma; Central Nervous System Tumors; Lymphomas; Wilms Tumor
  
• IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency
  ClinicalTrials.gov Identifier: NCT00228852 - Recruiting
  T-Cell Immune Deficiency Diseases; Severe Combined Immunodeficiency
  
• Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse
  ClinicalTrials.gov Identifier: NCT00002554 - Active, not recruiting
  recurrent adult acute myeloid leukemia; adult acute myeloid leukemia in remission
  
• Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00245037 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003060 - Active, not recruiting
  Recurrent Melanoma
  
• Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00469014 - Recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndrome; Chronic Myeloid Leukemia
  
• Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00024193 - Active, not recruiting
  stage 4S neuroblastoma
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00027924 - Active, not recruiting
  Myeloid Leukemia; Refractory Anemia
  
• Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00003414 - Active, not recruiting
  Lymphoma
  
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
  Breast Cancer
  
• Vitamin K Injections for the Treatment of Painful Menstruation
  ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
  Dysmenorrhea
  
• Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002789 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• IV Busulfan With Allo-BMT Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00469144 - Recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndrome; Leukemia
  
• Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002592 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
  ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
  Melanoma
  
• Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00004740 - Active, not recruiting
  Tuberculosis
  
• Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT
  ClinicalTrials.gov Identifier: NCT00516152 - Recruiting
  Chronic Myeloid Leukemia; Acute Myelogenous Leukemia; Myelodysplasia; Acute Lymphocytic Leukemia; Severe Aplastic Anemia; Non-Hodgkin's Lymphoma; Lymphoproliferative Disease; Multiple Myeloma; Advanced Myeloproliferative Disease
  
• Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00003081 - Active, not recruiting
  recurrent childhood rhabdomyosarcoma; adult rhabdomyosarcoma; recurrent peripheral primitive neuroectodermal tumor; ...
  
• Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00015873 - Active, not recruiting
  untreated childhood acute lymphoblastic leukemia
  
• Umbilical Cord Blood Transplantation in Treating Patients With Severe Aplastic Anemia, Malignant Thymoma, or Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00003336 - Active, not recruiting
  atypical chronic myeloid leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00005948 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia
  
• High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors
  ClinicalTrials.gov Identifier: NCT00060255 - Active, not recruiting
  Cancer
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
  ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
  Carcinoid Tumor; Acromegaly
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00006367 - Active, not recruiting
  idiopathic myelofibrosis; Polycythemia Vera; Essential Thrombocythemia; Agnogenic Myeloid Metaplasia
  
• Patients Preference With Self-Injection: The PRISM Study
  ClinicalTrials.gov Identifier: NCT00253396 - Recruiting
  Bruises
  
• Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
  ClinicalTrials.gov Identifier: NCT00076648 - Active, not recruiting
  Hemorrhagic Shock
  
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
  Diabetic Macular Edema
  
• Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00394030 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00087776 - Active, not recruiting
  Malignant Melanoma
  
• Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Releated
  ClinicalTrials.gov Identifier: NCT00582933 - Recruiting
  Leukemia; Myelodysplastic Syndrome; Non-Hodgkin's Lymphoma; Allogeneic Marrow Transplant
  
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
  ClinicalTrials.gov Identifier: NCT00003662 - Active, not recruiting
  Graft Versus Host Disease; Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; ...
  
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
  ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Study of TPI 287 in Patients with Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00113724 - Active, not recruiting
  Neoplasms
  
• A Study to Determine the Effectiveness and Safety of Risperidone in the Prevention of Bipolar Mood Episodes
  ClinicalTrials.gov Identifier: NCT00132678 - Active, not recruiting
  Bipolar Disorder
  
• Azithromycin/Bicillin for treatment of early syphilis
  ClinicalTrials.gov Identifier: NCT00031499 - Active, not recruiting
  Syphilis
  
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
  ClinicalTrials.gov Identifier: NCT00003913 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; myelodysplastic and myeloproliferative diseases